Are you a Business Owner?
Set up your Private Seller Account and create your listing todayGet Started Here
The company has developed an advanced technology platform with unique features for post marketing surveillance (PMS) data collection in Japan as well as providing a simplified system for capturing real world evidence (RWE) in the US, Europe and other markets. Established in 2002 the company has worked with many leading pharma companies.
• The system’s capability to combine electronic data capture and paper-based collection on an individual study which is unique to the company.
• The company service offering provides pharma companies with the functionality they require at a competitive price, due to the efficient study design and set up features.
• The Company is also CDISC certified. The system complies with both 21 CFR part 11 as well as Japanese ER/ES Guidelines.
• Exciting opportunity to companies intent on winning new pharma business in this large market where increasing digitisation of patient data is expected due to COVID-19.
• The company is seeking to out licence or sell its innovative system for use in Japan and potentially other Asian markets.
• Contract Research Organisations.
• Healthcare software/technology companies.
• Software application developers.
• Clinical solutions providers.
• Software companies engaged in life science sector.
• Digital health software providers.
If you own a business and are considering selling, visit our Sell a Business section. Limited Trial available.Sell Your Business